Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-20

Clinical Trial Update: Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 study updating dose titration of lisinopril in children (1-18 years) with primary or secondary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

Sponsor: University Ghent | Conditions: Primary Hypertension, Secondary Hypertension | Phase 4 | Status: COMPLETED